Release Date: 15/07/14 13:00 Summary: Appendix 3B - Exercise of Options Price Sensitive: No Download Document 549.03KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%